In melanoma, paradoxical activation of the MAPK pathway induced by BRAF inhibitors in macrophages results in upregulation and secretion of the vascular endothelial growth factor, which in turn restores MAPK signaling and promotes resistance in tumor cells [77]. The gene discussed is BRAF; the disease is neoplasm.